HİKMET GÜLŞAH TANYILDIZ, Şule YEŞİL, Ceyhun BOZKURT, Mehmet Onur ÇANDIR, Sibel AKPINAR TEKGÜNDÜZ, Şule TOPRAK, Deniz YÜKSEL, GÜRSES ŞAHİN

Are the methylenetetrahydrofolate reductase 1298 and 677 gene polymorphisms related to optic glioma and hamartoma risk in neurofibromatosis type 1 patients?

The methylenetetrahydrofolate reductase (MTHFR) gene plays a key role in carcinogenesis through its effects on DNA synthesis and methylation and also has a significant role in the etiology of many disorders, such as diabetes, migraine, and cardiovascular disease. Neurofibromatoses (NF) are autosomal dominant inherited diseases that can affect tissues such as bone and skin and predispose individuals to tumor development in various parts of the nervous system or body. Optic nerve glioma and brain tumors are common in children with NF, and leukemia and lymphoma incidence is also higher than normal. We therefore aimed to investigate the possible relationship between the MTHFR gene polymorphism and accompanying tumors such as neurofibroma, hamartoma, and optic glioma in children with NF1 found to have the MTHFR 677 and MTHFR 1298 gene polymorphism in this study. We included 55 pediatric patients diagnosed with NF1 between 2005 and 2014 in the study group. The control group included 44 healthy subjects without acute or chronic disease findings. A significant relationship was found between the MTHFR A1298C polymorphism and the incidence of optic glioma (p=0.014) (AA vs. AC: OR 11, 95% CI 1.27-95.17; AA vs. CC: OR 7.33, 95% CI 0.35-150.70). We also found a significant relationship between the MTHFR C1298C polymorphism and the incidence of hamartoma (p=0.019) (AA vs. AC: OR 2.12, 95% CI 0.662-6.809; p=0.203). Epilepsy incidence was high in subjects with MTHFR C677C. The MTHFR A1298C, C1298C, and C677C gene polymorphisms can be associated with a higher optic glioma, hamartoma, and epilepsy incidence, respectively, in patients diagnosed with neurofibromatosis type 1.

PDF

___

1. Dikmen M. Metilentetrahidrofolat redüktaz (MTHFR) enziminin moleküler biyolojisi ve hastalıklarla ilişkisi. Kocatepe Tıp Dergisi 2004; 5: 2: 9-16.

2. Çetintaş VB, Avcı ÇB, Süslüer SY, Eroğlu Z, Gündüz C. Meta-analiz: Türk toplumunda MTHFR c.677C>T polimorfizmi ve kanser ilişkisi. Ege Tıp Dergisi 2012; 51: 221-228.

3. Rosenblatt DS. Methylenetetrahydrofolate reductase. Clin Invest Med 2001; 24: 56-59.

4. Homberger A, Linnebank M, Winter C, et al. Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet 2000; 8: 725-729.

5. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red cells. Proc Natl Acad Sci USA 1998; 95: 13217- 13220.

6. Bailey LB, Duhaney RL, Maneval DR, et al. Vitamin B-12 status in inversely associated with plasma homocysteine in young women with C677T and/ or A1298C methylenetetrahydrofolate reductase polymorphisms. J Nutr 2002; 132: 1872-1878.

7. Kim Y. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: A paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 2000; 58: 205-209.

8. İzmirli M, Aldemir Ö, Göğebakan B, Alptekin D. MTHFR 677 C>T Polimorfizmi ile ilintili olduğu düşünülen hastalıklara dair Türk populasyonundaki çalışmalar. Dicle Tıp Dergisi 2014; 41: 244-256.

9. Goyette P, Rozen R. The thermolabile variant 677C-->T can further reduce activity when expressed in cis with severe mutations for human methylenetetrahydrofolate reductase. Hum Mutat 2000; 16: 132-138.

10. Yang QH, Botto LD, Gallagher M, et al. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 2008; 88: 232-246.

11. Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 2003; 153: 571-582.

12. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.

13. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001; 184: 806-812.

14. Izmirli M. A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk. Mol Biol Rep 2013; 40: 625-637.

15. Schwahn B, Rozen R. Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenomics 2001; 1: 189- 201.

16. Ozarda Y, Sucu DK, Hizli B, Aslan D. Rate of T alleles and TT genotype at MTHFR 677C>T locus or C alleles and CC genotype at MTHFR 1298 A>C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochem Funct 2009; 27: 568-577.

17. Hekim N, Ergen A, Yaylim I, et al. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct 2007; 25: 115-117.

18. Küçükhüseyin Ö, Kurnaz Ö, Akadam-Teker AB, Narter F, Yılmaz-Aydoğan H, İsbir T. Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer. Asian Pac J Cancer Prev 2011; 12: 2275-2278.

19. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000; 151: 862-877.

20. S h e n H , N e w m a n n A S , H u Z , e t a l . Methylenetetrahydrofolate reductase polymorphisms/ haplotypes and risk of gastric: a case-control analysis in China. Oncol Rep 2005; 13: 355-360.

21. Song CX, Ping L, Ting W. Folate, MTHFR C677T and A1298C polymorphisms with the relationship with ovarian cancer risk among Chinese females. Afr J Microbiol Res 2012; 6: 4761-4766.

22. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006; 131: 1271-1283.

23. Födinger M, Hörl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000; 13: 20-33.

24. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96: 12810-12815.

25. Wa n g H , Wa n g J , Z h a o L , L i u X , M i W. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet 2012; 13: 77.

26. Xu C, Yuan L, Tian H, Cao H, Chen S. Association of the MTHFR C677T polymorphism with primary brain tumor risk. Tumour Biol 2013; 34: 3457-3464.

27. Linnebank M, Semmler A, Moskau S, Smulders Y, Blom H, Simon M. The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro Oncol 2008; 10: 548-552.

28. Lu Q, Dai D, Zhao W, et al. Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis. Tumour Biol 2013; 34: 2801-2807.

29. Franco RF, Simões BP, Tone LG, Gabellini SM, Zago MA, Falcão RP. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001; 115: 616–618.

30. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98: 4004-4009.

31. Ames, BN. Cancer prevention and diet: help from single nucleotide polymorphisms. Proc Natl Acad Sci USA 1999; 96: 12216-12218.

32. Matsuo K, Hamajima N, Suzuki R, et al. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 2004; 77: 351-357.

33. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 2001; 358: 1935-1940.

34. Crott JW, Mashiyama ST, Ames BN, Fenech M. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 2001; 10: 1089-1096.

35. Huemer M, Mulder-Bleile R, Burda P, et al. Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency. J Inherit Metab Dis 2016; 39: 115-124.

36. Jadavji NM, Deng L, Malysheva O, Caudill MA, Rozen R. MTHFR deficiency or reduced intake of folate or choline in pregnant mice results in impaired short-term memory and increased apoptosis in the hippocampus of wild-type offspring. Neuroscience 2015; 300: 1-9.